Article Details

Integral Molecular joins FDA's ISTAND program - Labiotech.eu

Retrieved on: 2022-09-08 18:49:09

Tags for this article:

Click the tags to see associated articles and topics

Integral Molecular joins FDA's ISTAND program - Labiotech.eu. View article details on hiswai:

Excerpt

Integral Molecular said antibodies and antibody-based therapies, ... of monoclonal antibodies that can result in safety and toxicity issues.

Article found on: www.labiotech.eu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up